FDA's Guidance on Patient-Focused Outcome Measurement in Clinical Trials

With more and more digital health drug development tools (DDT) being used in clinical research I’m increasingly interested in understanding how we can differentiate these tools from status quo “gold standard” measures. What’s a sponsor’s incentive to use something other than the gold standard? Focusing on DDT’s objectivity, reliability, etc are important but I believe that focusing on what’s…